Clinical Research Directory
Browse clinical research sites, groups, and studies.
An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly
Sponsor: Camurus AB
Summary
The purpose of this study is to collect long-term (up to two years) safety and effectiveness of octreotide subcutaneous depot in patients with acromegaly in the real-world setting.
Official title: A Multi-Center, Multinational, Observational Study of Octreotide Subcutaneous Depot for the Treatment of Patients With Acromegaly
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2026-06-05
Completion Date
2029-06
Last Updated
2026-06-12
Healthy Volunteers
No
Conditions
Interventions
Octreotide subcutaneous depot
Commercially available octreotide subcutaneous depot treatment administered by participants for a maximum duration up to 2 years in the study
Locations (4)
Universitaetsklinikum Aachen
Aachen, Germany
Universitaetsklinikum Leipzig
Leipzig, Germany
Fachpraxis für Innere Medizin, Endokrinologie und Diabetologie
Magdeburg, Germany
Medicover Neuroendokrinologie MVZ
München, Germany